PRODUCT LITERATURE

The safety of bortezomib for the treatment of multiple myeloma

---

There is now 16 years’ worth of established results of various trials demonstrating the bortezomib efficiency in the treatment of multiple myeloma. Over this time, the introduction of bortezomib has been a major break through in the treatment of
multiple myeloma. Bortezomib can be administered in the outpatient setting with manageable toxicities.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Fonkozomib

Specific Detail Info

Expert Opinion on Drug Safety

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment